MedDataX Logo

Oocyte Cryopreservation by Slow Freezing and Vitrification

NCT ID: NCT01223105

Last Updated: 2013-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-07-31

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study seeks to evaluate whether the vitrification technique, as compared to the more traditional slow-cooling technique, leads to higher rates of successful thawing, fertilization, implantation and delivery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cryopreservation (freezing) of human gametes (unfertilized egg) provides a great potential to preserve or extend fertility in the face of disease and social circumstances (cancer diagnosis, delaying childbirth, single women, etc.). There are two methods for storage of oocytes (unfertilized eggs): slow freezing or vitrification (uses higher concentrations of cryoprotectant and faster cooling rates). Slow freezing is the standard method and has been successful for embryos since 1983 and more recently for oocytes. Recent reports indicate that vitrification may be more successful than slow freezing. The aim of this study is to examine the rate at which frozen eggs survive freezing and thawing, the rate at which the frozen/thawed eggs fertilize with sperm and the pregnancy outcomes of oocyte (egg) vitrification cycles to determine whether the outcomes are similar or better than standard oocyte (egg) cryopreservation (freezing) cycles.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Women Diagnosed With Cancer Egg Donors Single Women Failed Sperm Procurement in IVF

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

slow freeze cryopreservation vitrification oocyte preservation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Slow Freezing

oocytes will be frozen by slow freeze/ rapid thaw

Group Type EXPERIMENTAL

slow freeze

Intervention Type PROCEDURE

Eggs will be placed in a cryo-protected solution and frozen slowly in a programable freezer

Vitrification

oocytes will be frozen using rapid freezing/rapid thaw

Group Type EXPERIMENTAL

Vitrification

Intervention Type PROCEDURE

Eggs will be placed in a high concentration of cryo-protectant and frozen very quickly by plunging in liquid nitrogen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

slow freeze

Eggs will be placed in a cryo-protected solution and frozen slowly in a programable freezer

Intervention Type PROCEDURE

Vitrification

Eggs will be placed in a high concentration of cryo-protectant and frozen very quickly by plunging in liquid nitrogen

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cryopreservation Traditional freezing slow freezing

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 21 and 50 years, at the time of informed consent.
* Subjects must agree to undergo intracytoplasmic sperm injection (ICSI)

Exclusion Criteria

* Presence of any medical condition that contraindicates ovarian stimulation, in vitro fertilization or pregnancy.
Minimum Eligible Age

21 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Reproductive Medicine Associates of New Jersey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard T Scott, MD, HCLD

Role: STUDY_DIRECTOR

RMA of NJ

Kathleen Ferry, BS

Role: STUDY_CHAIR

RMA of NJ

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RMA-2009-02

Identifier Type: -

Identifier Source: org_study_id